Showing results (1-10 of 52) with videos related to
Sort By:
Pageof 6
ACS Chemical Neuroscience|April 4, 2017
Classics in Chemical Neuroscience: AripiprazoleAusten B Casey, Clinton E CanalBiochemical Pharmacology|April 5, 2022
"Selective" serotonin 5-HT2A receptor antagonistsAusten B Casey, Meng Cui, Raymond G Booth, et al.ACS Pharmacology & Translational Science|June 23, 2020
(S)-5-(2'-Fluorophenyl)-N,N-dimethyl-1,2,3,4-tetrahydronaphthalen-2-amine, a Serotonin Receptor Modulator, Possesses Anticonvulsant, Prosocial, and Anxiolytic-like Properties in an Fmr1 Knockout Mouse Model of Fragile X Syndrome and Autism Spectrum DisorderJessica L Armstrong, Austen B Casey, Tanishka S Saraf, et al.Handbook of Experimental Pharmacology|March 14, 2018
Serotonergic Psychedelics: Experimental Approaches for Assessing Mechanisms of ActionClinton E CanalACS Chemical Neuroscience|February 20, 2020
Structure-Activity Relationship Study of Psychostimulant Synthetic Cathinones Reveals Nanomolar Antagonist Potency of α-Pyrrolidinohexiophenone at Human Muscarinic M2 ReceptorsYiming Chen, Clinton E CanalACS Chemical Neuroscience|January 6, 2022
The Need To Improve Reporting of the Pharmacological Action of New MoleculesClinton E Canal, Marcello LeopoldoBioorganic & Medicinal Chemistry|December 29, 2019
Synthesis of novel 5-substituted-2-aminotetralin analogs: 5-HT1A and 5-HT7 G protein-coupled receptor affinity, 3D-QSAR and molecular modelingCharles K Perry, Austen B Casey, Daniel E Felsing, et al.Behavioral Neuroscience|August 1, 2007
Different temporal profiles of amnesia after intra-hippocampus and intra-amygdala infusions of anisomycinClinton E Canal, Paul E GoldJournal of Psychopharmacology (Oxford, England)|December 2, 2016
The serotonin 5-HT2C receptor and the non-addictive nature of classic hallucinogensClinton E Canal, Kevin S MurnaneBritish Journal of Pharmacology|October 22, 2025
History, pharmacology and therapeutic mechanisms of 3,4-methylenedioxymethamphetamine (MDMA)Austen B Casey, Boris D HeifetsPageof 6